Leach Jake's most recent trade in Dexcom Inc was a trade of 744 Common Stock done at an average price of $76.9 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.87 per share. | 16 Dec 2024 | 744 | 264,171 (0%) | 0% | 76.9 | 57,191 | Common Stock |
| Dexcom Inc | Jake Leach | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 69.15 per share. | 09 Sep 2024 | 746 | 264,915 (0%) | 0% | 69.2 | 51,586 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 23,894 | 23,894 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 115.05 per share. | 10 Jun 2024 | 745 | 265,577 (0%) | 0% | 115.1 | 85,713 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 4,469 | 4,469 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 134.41 per share. | 12 Mar 2024 | 14,639 | 273,913 (0%) | 0% | 134.4 | 1,967,638 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2024 | 7,736 | 266,177 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 26,053 | 288,552 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Leach Jake | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 9,697 | 266,477 (0%) | 0% | 0.0 | 10 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 3,978 | 262,499 (0%) | 0% | 123.6 | 491,819 | Common Stock |
| Dexcom Inc | Leach Jake | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 121.85 per share. | 18 Dec 2023 | 2,932 | 256,780 (0%) | 0% | 121.9 | 357,266 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 41,010 | 41,010 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 20 Apr 2023 | 30,764 | 259,613 (0%) | 0% | 125 | 3,845,500 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 7,986 | 294,960 (0%) | 0% | 111.4 | 889,632 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 4,583 | 290,377 (0%) | 0% | 111.4 | 510,542 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 3,540 | 302,946 (0%) | 0% | 111.4 | 394,352 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 25,397 | 306,486 (0%) | 0% | 0.0 | 25 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 114.45 per share. | 06 Mar 2023 | 10,425 | 288,808 (0%) | 0% | 114.4 | 1,193,116 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 115.13 per share. | 06 Mar 2023 | 7,719 | 281,089 (0%) | 0% | 115.1 | 888,706 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 199,071 | 199,071 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 6,741 | 79,019 (0%) | 0% | 0.0 | 7 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 2,065 | 75,637 (0%) | 0% | 406.1 | 838,507 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 1,317 | 77,702 (0%) | 0% | 406.1 | 534,777 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 891 | 74,746 (0%) | 0% | 406.1 | 361,797 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 2,925 | 72,247 (0%) | 0% | 0.0 | 3 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 541.36 per share. | 09 Sep 2021 | 1,248 | 69,337 (0%) | 0% | 541.4 | 675,617 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 542.00 per share. | 09 Sep 2021 | 15 | 69,322 (0%) | 0% | 542 | 8,130 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Aug 2021 | 50,000 | 50,000 (0%) | 0% | 1.5 | 76,885 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Aug 2021 | 50,000 | 150,000 (0%) | 0% | 1.5 | 77,095 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 16 Aug 2021 | 50,000 | 100,000 (0%) | 0% | 1.5 | 74,785 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 476.70 per share. | 30 Jul 2021 | 12,087 | 70,554 (0%) | 0% | 476.7 | 5,761,873 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 39,038 | 39,038 | - | - | Stock Option (right to buy) | |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 33,762 | 72,800 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 395.00 per share. | 09 Jun 2021 | 22,755 | 82,641 (0%) | 0% | 395 | 8,988,225 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 362.92 per share. | 10 Mar 2021 | 5,353 | 105,396 (0%) | 0% | 362.9 | 1,942,695 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 7,171 | 110,749 (0%) | 0% | 0.0 | 7 | Common Stock |
| SenesTech Inc | Jake Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 27,046 | 27,046 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 398.30 per share. | 09 Sep 2020 | 2,577 | 104,831 (0%) | 0% | 398.3 | 1,026,424 | Common Stock |
| Dexcom Inc | Jake Leach | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 398.30 per share. | 09 Sep 2020 | 1,283 | 103,548 (0%) | 0% | 398.3 | 511,021 | Common Stock |